Form 4 for TVRD Tvardi Therapeutics, Inc.

Accepted 2022-06-06 00:00:00 ET · period of report 2022-06-02 · accession 0001209191-22-034627 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-06-06	2022-06-02	TVRD	Shiff Susan Ph.D.	Dir	A - Grant	$0.00	+11.9K	19.1K	+165%	$0
D	2022-06-06	2022-06-02	TVRD	Shiff Susan Ph.D.	Dir	A - Grant	$0.00	+17.0K	17.0K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-06-02	A	A	11,876	$0.00	19,076	D	—	—	(F1) Represents the number of shares underlying restricted stock units ("RSUs") granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of (i) June 2, 2023 and (ii) immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date.
2	Derivative	Stock Option (Right to Buy)	2022-06-02	A	A	16,996	$0.00	16,996	D	$8.42 · — to 2032-06-02	16,996 Common Stock	(F2) This option was granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. The shares underlying the option vest and become exercisable on the earlier of (i) June 2, 2023 and (ii) immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date.